Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs

Naoto Kurihara, Tetsuro Kubota, Toshiharu Furukawa, Msahiko Watanabe, Yoshihide Otani, Koichiro Kumai, Masaki Kitajima

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The liver metastasis of gastric carcinoma is resistant to conventionally available treatment. Twenty patients with liver metastasis of gastric cancer were treated by arterial drug infusion using a reservoir and seven cases were treated with systemic chemotherapy. The resected primary gastric cancer specimen was used for chemosensitivity assay with 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) endpoint, and the patients were treated without reference to the results of the chemosensitivity assay. The mean survival period was assessed according to the histology of the primary lesion, the grade of liver metastasis and the presence of peritoneal dissemination. No significant differences were observed in the primary tumor histology and grade of liver metastasis, but the survival period of the patients with liver metastasis and peritoneal dissemination was significantly shorter than that of the patients without peritoneal dissemination. Nine patients were treated with drugs that were effective in the chemosensitivity assay, and their responses included two complete responses and two partial responses; these patients showed a significantly prolonged survival period compared with patients treated with drugs that were not effective in the assay. The chemosensitivity assay is useful for evaluating the effectiveness of antitumor agents against liver metastasis of gastric cancer.

Original languageEnglish
Pages (from-to)5155-5158
Number of pages4
JournalAnticancer Research
Volume19
Issue number6 B
Publication statusPublished - 1999 Nov

Fingerprint

Antineoplastic Agents
Stomach Neoplasms
Neoplasm Metastasis
Liver
Neoplasms
Survival
Histology
Pharmaceutical Preparations
Bromides
Stomach
Carcinoma
Drug Therapy

Keywords

  • Chemosensitivity assay
  • Gastric carcinoma
  • Liver metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs. / Kurihara, Naoto; Kubota, Tetsuro; Furukawa, Toshiharu; Watanabe, Msahiko; Otani, Yoshihide; Kumai, Koichiro; Kitajima, Masaki.

In: Anticancer Research, Vol. 19, No. 6 B, 11.1999, p. 5155-5158.

Research output: Contribution to journalArticle

Kurihara, N, Kubota, T, Furukawa, T, Watanabe, M, Otani, Y, Kumai, K & Kitajima, M 1999, 'Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs', Anticancer Research, vol. 19, no. 6 B, pp. 5155-5158.
Kurihara, Naoto ; Kubota, Tetsuro ; Furukawa, Toshiharu ; Watanabe, Msahiko ; Otani, Yoshihide ; Kumai, Koichiro ; Kitajima, Masaki. / Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs. In: Anticancer Research. 1999 ; Vol. 19, No. 6 B. pp. 5155-5158.
@article{fc98629e13c24399aa13e4af70c0f9e8,
title = "Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs",
abstract = "The liver metastasis of gastric carcinoma is resistant to conventionally available treatment. Twenty patients with liver metastasis of gastric cancer were treated by arterial drug infusion using a reservoir and seven cases were treated with systemic chemotherapy. The resected primary gastric cancer specimen was used for chemosensitivity assay with 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) endpoint, and the patients were treated without reference to the results of the chemosensitivity assay. The mean survival period was assessed according to the histology of the primary lesion, the grade of liver metastasis and the presence of peritoneal dissemination. No significant differences were observed in the primary tumor histology and grade of liver metastasis, but the survival period of the patients with liver metastasis and peritoneal dissemination was significantly shorter than that of the patients without peritoneal dissemination. Nine patients were treated with drugs that were effective in the chemosensitivity assay, and their responses included two complete responses and two partial responses; these patients showed a significantly prolonged survival period compared with patients treated with drugs that were not effective in the assay. The chemosensitivity assay is useful for evaluating the effectiveness of antitumor agents against liver metastasis of gastric cancer.",
keywords = "Chemosensitivity assay, Gastric carcinoma, Liver metastasis",
author = "Naoto Kurihara and Tetsuro Kubota and Toshiharu Furukawa and Msahiko Watanabe and Yoshihide Otani and Koichiro Kumai and Masaki Kitajima",
year = "1999",
month = "11",
language = "English",
volume = "19",
pages = "5155--5158",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs

AU - Kurihara, Naoto

AU - Kubota, Tetsuro

AU - Furukawa, Toshiharu

AU - Watanabe, Msahiko

AU - Otani, Yoshihide

AU - Kumai, Koichiro

AU - Kitajima, Masaki

PY - 1999/11

Y1 - 1999/11

N2 - The liver metastasis of gastric carcinoma is resistant to conventionally available treatment. Twenty patients with liver metastasis of gastric cancer were treated by arterial drug infusion using a reservoir and seven cases were treated with systemic chemotherapy. The resected primary gastric cancer specimen was used for chemosensitivity assay with 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) endpoint, and the patients were treated without reference to the results of the chemosensitivity assay. The mean survival period was assessed according to the histology of the primary lesion, the grade of liver metastasis and the presence of peritoneal dissemination. No significant differences were observed in the primary tumor histology and grade of liver metastasis, but the survival period of the patients with liver metastasis and peritoneal dissemination was significantly shorter than that of the patients without peritoneal dissemination. Nine patients were treated with drugs that were effective in the chemosensitivity assay, and their responses included two complete responses and two partial responses; these patients showed a significantly prolonged survival period compared with patients treated with drugs that were not effective in the assay. The chemosensitivity assay is useful for evaluating the effectiveness of antitumor agents against liver metastasis of gastric cancer.

AB - The liver metastasis of gastric carcinoma is resistant to conventionally available treatment. Twenty patients with liver metastasis of gastric cancer were treated by arterial drug infusion using a reservoir and seven cases were treated with systemic chemotherapy. The resected primary gastric cancer specimen was used for chemosensitivity assay with 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) endpoint, and the patients were treated without reference to the results of the chemosensitivity assay. The mean survival period was assessed according to the histology of the primary lesion, the grade of liver metastasis and the presence of peritoneal dissemination. No significant differences were observed in the primary tumor histology and grade of liver metastasis, but the survival period of the patients with liver metastasis and peritoneal dissemination was significantly shorter than that of the patients without peritoneal dissemination. Nine patients were treated with drugs that were effective in the chemosensitivity assay, and their responses included two complete responses and two partial responses; these patients showed a significantly prolonged survival period compared with patients treated with drugs that were not effective in the assay. The chemosensitivity assay is useful for evaluating the effectiveness of antitumor agents against liver metastasis of gastric cancer.

KW - Chemosensitivity assay

KW - Gastric carcinoma

KW - Liver metastasis

UR - http://www.scopus.com/inward/record.url?scp=0033367019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033367019&partnerID=8YFLogxK

M3 - Article

C2 - 10697526

AN - SCOPUS:0033367019

VL - 19

SP - 5155

EP - 5158

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -